Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony …

SH Yoon, YS Shim, YH Park, JK Chung, JH Nam… - Stem …, 2007 - academic.oup.com
To assess the safety and therapeutic efficacy of autologous human bone marrow cell (BMC)
transplantation and the administration of granulocyte macrophage-colony stimulating factor …

GM-CSF inhibits glial scar formation and shows long-term protective effect after spinal cord injury

X Huang, JM Kim, TH Kong, SR Park, Y Ha… - Journal of the …, 2009 - Elsevier
OBJECT: This study investigated the effects of granulocyte macrophage-colony stimulating
factor (GM-CSF) on the scar formation and repair of spinal cord tissues in rat spinal cord …

A review of the complexity adjustment in the Korean Diagnosis-Related Group (KDRG)

S Kim, C Jung, J Yon, H Park, H Yang… - Health Information …, 2020 - journals.sagepub.com
Background: The Korean Diagnosis-Related Groups (KDRG) was revised in 2003,
modifying the complexity adjustment mechanism of the Australian Refined Diagnosis …

GM-CSF inhibits apoptosis of neural cells via regulating the expression of apoptosis-related proteins

X Huang, JK Choi, SR Park, Y Ha, H Park… - Neuroscience …, 2007 - Elsevier
Recently, we reported that GM-CSF showed therapeutic effects on the spinal cord injury
(SCI) in rat model possibly via its anti-apoptotic activity in the nervous system. This study …

Granulocyte macrophage-colony stimulating factor shows anti-apoptotic activity in neural progenitor cells via JAK/STAT5-Bcl-2 pathway

JK Choi, KH Kim, H Park, SR Park, BH Choi - Apoptosis, 2011 - Springer
Recently, many studies have shown that granulocyte macrophage-colony stimulating factor
(GM-CSF) has anti-apoptotic activity and regulates the expression of anti-apoptotic genes …

Granulocyte–macrophage colony‐stimulating factor promotes survival of dopaminergic neurons in the 1‐methyl‐4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine‐induced …

NK Kim, BH Choi, X Huang, BJ Snyder… - European Journal of …, 2009 - Wiley Online Library
Granulocyte–macrophage colony‐stimulating factor (GM‐CSF) is a hematopoietic cytokine
that has the potential for clinical application. The biological effects of GM‐CSF have been …

Reduction in programmed cell death and improvement in functional outcome of transient focal cerebral ischemia after administration of granulocyte-macrophage …

TH Kong, JK Choi, H Park, BH Choi, BJ Snyder… - Journal of …, 2009 - thejns.org
Object Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a potent
hematopoietic growth factor that both enhances the survival and drives the differentiation …

Hypoxia-inducible expression of vascular endothelial growth factor for the treatment of spinal cord injury in a rat model

BH Choi, Y Ha, X Huang, SR Park, J Chung… - … of Neurosurgery: Spine, 2007 - thejns.org
Object Vascular endothelial growth factor (VEGF) has been investigated as a therapy for
many disorders and injuries involving ischemia. In this report, we constructed and evaluated …

Factors influencing the incidence and treatment of intracranial aneurysm and subarachnoid hemorrhage: time trends and socioeconomic disparities under an …

WK Lee, CW Oh, H Lee, KS Lee, H Park - Journal of …, 2019 - jnis.bmj.com
Background Despite increasing usage of endovascular treatments for intracranial
aneurysms, few research studies have been conducted on the incidence of unruptured …

A hypoxia-inducible gene expression system using erythropoietin 3′ untranslated region for the gene therapy of rat spinal cord injury

BH Choi, Y Ha, CH Ahn, X Huang, JM Kim, SR Park… - Neuroscience …, 2007 - Elsevier
Many neurologic disorders are accompanied by ischemic injury during the pathologic
process. To develop a controllable and injury-specific gene therapy system for the …